Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic Potential ofα7 Nicotinic Acetylcholine Receptors
Daniel Bertrand, Chih-Hung L. Lee, Dorothy G. Flood, et al.
Pharmacological Reviews (2015) Vol. 67, Iss. 4, pp. 1025-1073
Open Access | Times Cited: 130

Showing 76-100 of 130 citing articles:

JWX-A0108, a positive allosteric modulator of α7 nAChR, attenuates cognitive deficits in APP/PS1 mice by suppressing NF-κB-mediated inflammation
Hui Li, Jie Gao, Yue Chang, et al.
International Immunopharmacology (2021) Vol. 96, pp. 107726-107726
Closed Access | Times Cited: 11
Probing the molecular basis for signal transduction through the Zinc-Activated Channel (ZAC)
Nawid Madjroh, Eleni Mellou, Laura Æbelø, et al.
Biochemical Pharmacology (2021) Vol. 193, pp. 114781-114781
Open Access | Times Cited: 11
In vivo and in vitro ADMET profiling and in vivo pharmacodynamic investigations of a selective α7 nicotinic acetylcholine receptor agonist with a spirocyclic Δ 2 -isoxazoline molecular skeleton
Carlo Matera, Giulio Dondio, Daniela Braida, et al.
European Journal of Pharmacology (2017) Vol. 820, pp. 265-273
Closed Access | Times Cited: 12
Designing selective modulators for the nicotinic receptor subtypes: challenges and opportunities
Dina Manetti, Cristina Bellucci, Niccolò Chiaramonte, et al.
Future Medicinal Chemistry (2018) Vol. 10, Iss. 4, pp. 433-460
Open Access | Times Cited: 12
Longitudinal PET Imaging of α7 Nicotinic Acetylcholine Receptors with [18F]ASEM in a Rat Model of Parkinson’s Disease
Steven Vetel, Johnny Vercouillie, Frédéric Buron, et al.
Molecular Imaging and Biology (2019) Vol. 22, Iss. 2, pp. 348-357
Closed Access | Times Cited: 12
Probing the Cholinergic System to Understand Neurodegenerative Diseases
Pierre‐Yves Renard, Ludovic Jean
Future Medicinal Chemistry (2017) Vol. 9, Iss. 2, pp. 131-133
Open Access | Times Cited: 11
Allosteric Activation of α7 Nicotinic Acetylcholine Receptors by Novel 2-Arylamino-thiazole-5-carboxylic Acid Amide Derivatives for the Improvement of Cognitive Deficits in Mice
Chenxia Yang, Ying Meng, Xintong Wang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6344-6364
Closed Access | Times Cited: 1
CHRNA7 Deletions are Enriched in Risperidone-Treated Children and Adolescents
Madelyn A. Gillentine, Janson J. White, Christopher M. Grochowski, et al.
Journal of Child and Adolescent Psychopharmacology (2017) Vol. 27, Iss. 10, pp. 908-915
Open Access | Times Cited: 10
Nicotinic receptor dependent regulation of cough and other airway defensive reflexes
Mayuko Tao, Qi Liu, Yasunari Miyazaki, et al.
Pulmonary Pharmacology & Therapeutics (2019) Vol. 58, pp. 101810-101810
Closed Access | Times Cited: 10
Heteromeric Neuronal Nicotinic Acetylcholine Receptors with Mutant β Subunits Acquire Sensitivity to α7-Selective Positive Allosteric Modulators
Clare Stokes, Sumanta Garai, Abhijit Kulkarni, et al.
Journal of Pharmacology and Experimental Therapeutics (2019) Vol. 370, Iss. 2, pp. 252-268
Open Access | Times Cited: 10
The development of novel polypharmacological agents targeting the multiple binding sites of nicotinic acetylcholine receptors
Miguel Reyes‐Parada, Patricio Iturriaga‐Vásquez
Expert Opinion on Drug Discovery (2016) Vol. 11, Iss. 10, pp. 969-981
Closed Access | Times Cited: 9
Varenicline improves motor and cognitive deficits and decreases depressive-like behaviour in late-stage YAC128 mice
Ailsa L. McGregor, Gary X. D’Souza, Donghyo Kim, et al.
Neuropharmacology (2016) Vol. 116, pp. 233-246
Open Access | Times Cited: 9
S-oxiracetam Facilitates Cognitive Restoration after Ischemic Stroke by Activating α7nAChR and the PI3K-Mediated Pathway
Wenxiang Fan, Ying Zhang, Xiaomin Li, et al.
Neurochemical Research (2021) Vol. 46, Iss. 4, pp. 888-904
Closed Access | Times Cited: 9
Discovery and Development of Non-Dopaminergic Agents for the Treatment of Schizophrenia: Overview of the Preclinical and Early Clinical Studies
Agnieszka Jankowska, Grzegorz Satała, Anna Partyka, et al.
Current Medicinal Chemistry (2019) Vol. 26, Iss. 25, pp. 4885-4913
Closed Access | Times Cited: 9
An integral perspective of canonical cigarette and e-cigarette-related cardiovascular toxicity based on the adverse outcome pathway framework
Ruiyang Ding, Xiaoke Ren, Qinglin Sun, et al.
Journal of Advanced Research (2022)
Open Access | Times Cited: 6
GTS-21 Enhances Regulatory T Cell Development from T Cell Receptor-Activated Human CD4+ T Cells Exhibiting Varied Levels of CHRNA7 and CHRFAM7A Expression
Masato Mashimo, Takeshi Fujii, Shiro Ono, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12257-12257
Open Access | Times Cited: 3
Probing the putative α7 nAChR/NMDAR complex in human and murine cortex and hippocampus: Different degrees of complex formation in healthy and Alzheimer brain tissue
Mohamed R. Elnagar, Anne B. Walls, Gouda K. Helal, et al.
PLoS ONE (2017) Vol. 12, Iss. 12, pp. e0189513-e0189513
Open Access | Times Cited: 8
Cholinergic and purinergic systems: A key to multiple sclerosis?
Carla Roberta Nunes Polachini, Rosélia Maria Spanevello, Maria Rosa Chitolina Schetinger, et al.
Journal of the Neurological Sciences (2018) Vol. 392, pp. 8-21
Closed Access | Times Cited: 8
Cholinergic anti-inflammatory pathway and COVID-19.
Danial Mehranfard, Robert C. Speth
DOAJ (DOAJ: Directory of Open Access Journals) (2022) Vol. 12, Iss. 2, pp. 171-174
Closed Access | Times Cited: 5
Oligo-basic amino acids, potential nicotinic acetylcholine receptor inhibitors
Baojian Zhang, Maomao Ren, Fang Yang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 152, pp. 113215-113215
Open Access | Times Cited: 5
Allosteric Modulators of Potential Targets Related to Alzheimer's Disease: a Review
Guilherme Martins Silva, Mariana Pegrucci Barcelos, João Gabriel Curtolo Poiani, et al.
ChemMedChem (2019) Vol. 14, Iss. 16, pp. 1467-1483
Open Access | Times Cited: 7
Therapeutics for dementia and Alzheimer's disease: New directions for precision medicine
James A. Duce, Xiongwei Zhu, Laura H. Jacobson, et al.
British Journal of Pharmacology (2019) Vol. 176, Iss. 18, pp. 3409-3412
Open Access | Times Cited: 7
LL-00066471, a novel positive allosteric modulator of α7 nicotinic acetylcholine receptor ameliorates cognitive and sensorimotor gating deficits in animal models: Discovery and preclinical characterization
Mahip Verma, Rajan Goel, Anand M. Bokare, et al.
European Journal of Pharmacology (2020) Vol. 891, pp. 173685-173685
Closed Access | Times Cited: 7
In silico Gene Set and Pathway Enrichment Analyses Highlight Involvement of Ion Transport in Cholinergic Pathways in Autism: Rationale for Nutritional Intervention
Audrey Olson, Fuquan Zhang, Hongbao Cao, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 6
GTS-21 Enhances Regulatory T Cell Development from T Cell Receptor-activated Human CD4<sup>+</sup> T Cells Exhibiting Varied Levels of <em>CHRNA7</em> and <em>CHRFAM7A </em>Expression
Masato Mashimo, Takeshi Fujii, Shiro Ono, et al.
(2023)
Open Access | Times Cited: 2

Scroll to top